The detection of antibodies against Schistosoma mansoni soluble egg antigens (SEA) and CEF6 in ELISA, before and after chemotherapy.
Doenhoff, MJ;
Wheeler, JG;
Tricker, K;
Hamilton, JV;
Sturrock, RF;
Butterworth, AE;
Ouma, JH;
Mbugua, GG;
Kariuki, C;
Koech, D;
(2003)
The detection of antibodies against Schistosoma mansoni soluble egg antigens (SEA) and CEF6 in ELISA, before and after chemotherapy.
Annals of tropical medicine and parasitology, 97 (7).
pp. 697-709.
ISSN 0003-4983
DOI: https://doi.org/10.1179/000349803225002354
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
Circulating IgG antibody reactivity and excreted egg counts were investigated in 489 Kenyans given chemotherapy for schistosomiasis mansoni. Antibody reactivity was measured in ELISA, using either unfractionated aqueous soluble constituents of Schistosoma mansoni eggs (SEA) or CEF6 (a soluble fraction of S. mansoni eggs containing two cationic antigens) as the antigen source. Antibody reactivity for each antigen source was strongly associated with egg counts, both pre- and post-treatment. Approximately 6 months after chemotherapy, egg counts were zero in 84% of the subjects. The mean optical densities (OD) measured in the post-treatment ELISA were 60% (CEF6) or 45% (SEA) lower than the pre-treatment values, the reduction in the OD with CEF6 as antigen source being significantly greater than that observed with SEA (P <0.001). The usefulness of an assay for antibody reactivity in monitoring the effects of the treatment of schistosomiasis is discussed.
